Previous in vitro studies have established a pre-transfer proofreading mechanism for editing of homocysteine by bacterial methionyl-, isoleucyl-, and valyl-tRNA synthetases. The unusual feature of the editing is the formation of a distinct compound, homocysteine thiolactone. Now, twodimensional TLC analysis of 35S-labeled amino acids extracted from cultures of the bacterium Escherichia coli reveals that the thiolactone is also synthesized in vivo. In E. coli, the thiolactone is made from homocysteine in a reaction catalyzed by methionyl-tRNA synthetase. One molecule of homocysteine is edited as thiolactone per 109 molecules of methionine incorporated into protein in vivo. These results not only directly demonstrate that the adenylate proofreading pathway for rejection of misactivated homocysteine operates in vivo in E. coli but, in general, establish the importance of error-editing mechanisms in living cells. Aminoacylation of tRNA is a two-step reaction. In the first step, an amino acid (AA) is activated to form enzyme (E)-bound aminoacyl adenylate.
dimensional TLC analysis of 35S-labeled amino acids extracted from cultures of the bacterium Escherichia coli reveals that the thiolactone is also synthesized in vivo. In E. coli, the thiolactone is made from homocysteine in a reaction catalyzed by methionyl-tRNA synthetase. One molecule of homocysteine is edited as thiolactone per 109 molecules of methionine incorporated into protein in vivo. These results not only directly demonstrate that the adenylate proofreading pathway for rejection of misactivated homocysteine operates in vivo in E. coli but, in general, establish the importance of error-editing mechanisms in living cells.
The synthesis of functional proteins depends on accurate transcription and translation of genetic information. To accomplish this with the least possible expenditure of energy, cells would have to evolve mechanisms capable of achieving accuracies better than 1 error in i-101.
Two steps of protein synthesis are important for accurate translation of genetic information: the selection of amino acids for aminoacylation of tRNA by synthetases and the selection of aminoacyl-tRNA in the codon-programmed ribosomal A site. The accuracy of initial amino acid selection for tRNA aminoacylation is far greater than the accuracy of subsequent ribosomal processes (1) . During selection of amino acids, synthetases very often have to distinguish the cognate substrate from a homologue having just one methyl group less in its structure. The binding energy of a methyl group is estimated to contribute only a factor of 102 to the specificity of binding (2) , yet synthetases distinguish such closely related amino acids with a discrimination factor of 104-105 (3, 4) . Examples of this include isoleucine vs. valine, alanine vs. glycine, threonine vs. serine, and methionine vs. homocysteine.
Aminoacylation of tRNA is a two-step reaction. In the first step, an amino acid (AA) is activated to form enzyme (E)-bound aminoacyl adenylate.
E + AA + ATP -* E-AA-AMP + PP, In the second step, the amino acid is transferred from the adenylate to tRNA.
E-AA-AMP + tRNAAA -* E + AAAtRNAAA + AMP Extraordinary fidelity of the tRNA aminoacylation reaction is due to enzymatic proofreading or editing activities of aminoacyl-tRNA synthetases (5, 6) . It has been proposed that aminoacyl-tRNA synthetases can exercise kinetic proofreading of incorrect substrates (7, 8) . Editing can occur by the hydrolysis of the noncognate aminoacyl adenylate (9) (10) (11) or the aminoacyl-tRNA (12) (13) (14) (15) . Both editing mechanisms have been directly demonstrated in vitro. Although it has been inferred from the in vitro studies that editing is also important in vivo, direct evidence for this was missing.
The aminoacyl-adenylate proofreading pathway originally discovered with valyl-tRNA synthetase (9, 10) has subsequently been established in vitro to be of major importance with several other synthetases (11) . In particular, methionyl-, isoleucyl-, and valyl-tRNA synthetases edited misactivated homocysteine by the adenylate pathway with the formation of homocysteine thiolactone. This feature of the homocysteine editing reaction provides a means to assay for editing in vivo by looking for a special product of editing, i.e., homocysteine thiolactone. I now report that homocysteine thiolactone is in fact synthesized in vivo by the bacterium Escherichia coli. The data indicate that the thiolactone synthesis in E. coli is due to efficient in vivo editing of homocysteine by methionyl-tRNA synthetase, thus establishing the existence and importance of proofreading in vivo. 1D). In contrast to what was expected, the methioninestarved metE mutant did not accumulate homocysteine ( Fig.  1 B-D (20) . As shown in Fig. 2 than that in the metE strain. A Met+ revertant of the metG strain, metG+-I, did not synthesize any detectable levels of thiolactone (Fig. 2) . Table 1 shows the intracellular concentrations of methionine, homocysteine, and homocysteine thiolactone in four E. coli strains. The concentrations of methionine and homocysteine in wild-type cells determined in this study are within a factor of 2 with respect to the concentrations determined in another wild-type E. coli (21) . To my knowledge, the thiolactone has not been reported in bacterial cells before. However, as shown in Table 1 , it is a significant component of the sulfur amino acids pool in E. coli.
MATERIALS AND METHODS
Unexpectedly, a methionine-starved metE mutant did not accumulate homocysteine (Table 1) . Instead, it accumulated the thiolactone. The intracellular concentration of homocysteine in metE was in fact 6.6-fold lower and the concentration of the thiolactone was 3.5-fold higher than in wild type. Some of the increase in rate of the thiolactone synthesis may also be due to a higher level of methionyl-tRNA synthetase in metE than in wild-type cells. Upon shift to medium lacking methionine, the level of methionyl-tRNA synthetase in metE cells decreased from about 5-fold over wild type before the shift, to 2-fold over wild type after 30 min without methionine (data not shown), as expected (22) . Thus, the increase in the rate of the thiolactone synthesis in metE over wild type is mostly due to the absence of methionine in metE cells. As will be shown below, methionine prevents the thiolactone synthesis.
Intracellular levels of methionine were lower and the level of homocysteine was higher in a metG-strain than in wild type (Table 1 ). This in itself would lead to higher rates of the thiolactone synthesis. Thus, the defect in the thiolactone synthesis is apparently due to the metG-mutation, which results in 17-fold higher Km values for the amino acid substrates (data not shown).
The intracellular levels of methionine and homocysteine in the metG+-1 revertant were similar to those in wild type, yet there was no synthesis of the thiolactone in the revertant.
Methionyl-tRNA synthetase in the metG+-1 strain differs slightly from that in metG-. The Km for methionine decreased 1.5-fold and the Vmax increased 1.9-fold relative to metG-, resulting in 3-fold higher specificity (Vma/Km) of the methionyl-tRNA synthetase present in metG+-J over that in metG-(data not shown). Although the differences were small, they were reproducible. These results suggest that the metG+-I revertant acquired a second point mutation affecting either the amino acid binding site ofthe methionyl-tRNA synthetase or its interaction with tRNA, either ofwhich could abolish the thiolactone-forming activity of the enzyme.
Previous attempts to genetically map mutations leading to prototrophy of the metG-strain failed due to the lack of markers in the metG region of the E. coli chromosome (20) and therefore were not repeated here.
Rate of Homocysteine Thiolactone Synthesis Is Directly Proportional to Cellular Levels ofMethionyl-tRNA Synthetase. The cellular level of Met-tRNA synthetase was manipulated in E. coli strain HD1 harboring pRS734, a plasmid bearing the methionyl-tRNA synthetase gene under control of the lac promoter; the relationship between the synthetase concentration and homocysteine thiolactone synthesis was studied. The rate of the thiolactone synthesis in the HD1/pRS734 culture increased upon induction with isopropyl P-D-thiogalactopyranoside (IPTG, 3 hr) from 0.7 pmol/hr to 3.5 pmol/hr (Fig. 3A) , which paralleled the increase in the levels of methionyl-tRNA synthetase from 0.5 unit to 2.75 units (data not shown). The rate of protein synthesis was the same in noninduced and induced cultures (Fig. 3B) . Comparison of the rate of the thiolactone synthesis (Fig. 3A) with the rate of protein synthesis (Fig. 3B) levels and the rate of thiolactone formation were determined for each culture. Fig. 4 shows that there was a direct relationship between the level of methionyl-tRNA synthetase and the rate of homocysteine thiolactone synthesis in bacterial cells. The regression line describing the relationship extrapolated to 0.1 pmol of thiolactone at zero methionyltRNA synthetase, which indicates that at least 80% of the thiolactone synthesis in wild-type cells is due to the synthetase. Synthesis of Homocysteine Thiolactone Is Inhibited by Methionine and Norleucine. Methionine, the natural substrate of methionyl-tRNA synthetase, totally abolished synthesis of the thiolactone by all strains tested (Table 2) . Norleucine, an artificial substrate of the synthetase (15), also prevented synthesis of the thiolactone. However, inhibition of the thiolactone formation in this case resulted in accumulation of homocysteine (data not shown), which confirms that homocysteine is the direct precursor of the thiolactone in vivo. Ethionine, another artificial substrate for methionyl-tRNA synthetase, was much less inhibitory (data not shown), perhaps because of its limited transport into cells due to its larger size than norleucine and methionine. Several other amino acids (isoleucine, valine, leucine, and arginine) did not have any significant effect on the thiolactone synthesis by the metE strain ( Table 2 ). The inhibitory effect of valine on thiolactone synthesis by the wild-type strain was probably due to valine-induced starvation for isoleucine (24) , since addition of isoleucine reversed the inhibition. Isoleucine alone and leucine alone had only minor effects on the thiolactone synthesis by the wild-type strain, as did arginine (Table 2) . That isoleucine, valine, and leucine did not inhibit synthesis of the thiolactone was further confirmed by observations that levels of homocysteine thiolactone in ilv, leu, and thr E. coli cultures were not increased by starvation. The thiolactone levels, in fact, decreased somewhat in starved ilv, leu, and thr cultures (data not shown), similar to effects observed in starved arg ( Fig. 1 E and F) and wild-type Met-tRNA synthetase, units cultures starved for isoleucine by valine addition ( Table 2) . These data exclude any significant participation of isoleucyl-, valyl-, or leucyl-tRNA synthetase in homocysteine thiolactone synthesis in E. coli. Instead, the results indicate that methionyl-tRNA synthetase is the primary enzyme involved in the thiolactone synthesis in bacterial cells.
DISCUSSION
This study confirms the in vivo existence of an efficient proofreading mechanism that prevents incorporation of homocysteine into tRNA and protein in the bacterium E. coli. It also directly shows that proofreading in general is important in living cells. Both genetic and biochemical evidence presented above indicate that homocysteine is transformed into homocysteine thiolactone by methionyl-tRNA synthetase in E. coli, an editing reaction previously discovered in vitro (11) . The thiolactone has not been reported in living cells before. As shown here (Table 1) , it is a significant component of sulfur amino acid pools in E. coli. The thiolactone was formed at a rate of 1 pmol per 2 x 106 cells per hr (Figs. 2-4 ) and accumulated within cells at a relatively low concentration of 1.2 pmol per 108 cells (Table 1) . Thus, most of the thiolactone was secreted from bacterial cells and was in fact found in cell-free medium (data not shown). E. coli has the capacity of metabolizing the thiolactone to methionine since some met mutants (e.g., metA) are able to grow on homocysteine thiolactone (unpublished data).
In addition to methionyl-tRNA synthetase, several other aminoacyl-tRNA synthetases edit misactivated homocysteine by transforming it into thiolactone in vitro (11, 25 
